Operative Treatment for Osteochondral Lesions of the Talus: Bone Marrow Aspirate Concentrate and Matrix-induced Chondrogenesis
10.14193/jkfas.2020.24.2.61
- Author:
Bom Soo KIM
1
;
Yeop NA
;
Won-Hwan KWON
Author Information
1. Department of Orthopaedic Surgery, Inha University College of Medicine, Korea
- Publication Type:Review Article
- From:Journal of Korean Foot and Ankle Society
2020;24(2):61-68
- CountryRepublic of Korea
- Language:0
-
Abstract:
Bone marrow aspirate concentrate and matrix-induced chondrogenesis (BMIC) is an interesting treatment option for osteochondral lesions of the talus with promising short- to mid-term results. The various terminologies used to describe this surgical method need to be addressed. These include bone marrow-derived cell transplantation, matrix-induced bone marrow aspirate concentrate, and matrixassociated stem cell transplantation. BMIC is a one-stage, minimally invasive surgery performed arthroscopically or using a mini-open arthrotomy approach without a malleolar osteotomy in most cases. The lesion is replaced with hyaline-like cartilage, and treatmentrelated complications are rare. BMIC is a safe and effective treatment option and should be considered in large lesions or lesions with a prior treatment history.
